New drugs show promise in treating deadly melanoma
|
|
( Business Wire ) PLX4032, or vemurafenib, is the first chemotherapy agent directed at a specific mutation involved in the formation of skin tumors, which occurs in about half of melanoma patients. Ipilimumab, marketed as Yervoy, stimulates the immune system to fight tumors, and has proven to be more effective than both conventional chemotherapy and a vaccine used to treat melanoma. Researchers reported the findings on June 5 at a meeting of the American Society of Clinical Oncology. |
E-mail
Twitter
Facebook
Read This Later
Comments are filtered for language and registration is required. The Times makes no guarantee of comments' factual accuracy. Readers may report inappropriate comments by clicking the Report Abuse link next to a comment. Here are the full legal terms you agree to by using this comment form.
L.A. for less than the price of sunblock. 
Currently there are no comments. Be the first to comment!